公开(公告)号：US20170320833A1

公开(公告)日：2017-11-09

申请号：US15654905

申请日：2017-07-20

Applicant: BRISTOL-MYERS SQUIBB COMPANY

Inventor： MAKONEN BELEMA ,  Van N. Nguyen

IPC: C07D233/64 ,  C07D413/14 ,  C07D409/14 ,  C07D405/14 ,  C07D403/14 ,  C07D401/14 ,  A61K45/06 ,  C07D417/14 ,  A61K31/4178

CPC classification number: C07D233/64 ,  A61K31/4178 ,  A61K45/06 ,  C07D207/16 ,  C07D401/14 ,  C07D403/14 ,  C07D405/14 ,  C07D409/14 ,  C07D413/14 ,  C07D417/14 ,  C07F5/025 ,  C07F7/0812

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.